Skip to main content
OpenTrials
Completed

NCT Number: NCT02188004

The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases

primary purpose:Evaluate the prevalence and incidence of HPV infection and related diseases in subjects.

Secondary purpose:Analyze risk factors of HPV infection and related diseases.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ages 18 to 55 years;
  • residents of the study site;
  • at least one sex partner;
  • Be able to understand and comply with the request of the protocol.

Exclusion criteria

  • pregnant;
  • has received HPV vaccines.

Treatment and study plan

Primary outcomes

  1. prevalence and incidence of HPV infection

    Time frame: 1 year

    Evaluate the prevalence and incidence of HPV infection and related diseases in subjects

Secondary outcomes

  1. risk factors of HPV infection and related diseases

    Time frame: 1 year

    Analyze risk factors of HPV infection and related diseases.

Sponsors and collaborators

Lead sponsor

Jun Zhang

Other

Collaborators

  • Liuzhou center of disease prevention and control

Registry information

Official study title

The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases In Male and Female Aged Over 18 Years In China

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Jul 11, 2014
Registry last updated
May 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.